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Playing the system 
to give low-impact 
journal more clout
SIR — A hundred years or so ago, 
a patent officer who was bored 
with his routine work wrote up 
his speculations on light quanta 
(A. Einstein Ann. Phys. 17, 132–
148; 1905), citing other people’s 
work to avoid long explanations. 
Today, there is a whole citation 
industry that — among other 
things — affects the impact 
factors of scientific journals, 
which in turn provide a gauge 
for the quality of an institution’s 
research output.
Publication in prestigious 
journals that have high impact 
factors encourages researchers 
to pursue trendy topics. It follows 
that investigators working in low-
profile and under-researched 
fields are at a disadvantage 
because they publish in less well-
known journals and generate 
fewer citations. This not only 
offends their institutions; in 
countries such as the Czech 
Republic it could fail to stimulate 
the flow of grant money.
The Swiss journal Folia 
Phoniatrica et Logopaedica 
has a good reputation among 
voice researchers but, with an 
impact factor of 0.655 in 2007, 
publication in it was unlikely to 
bring honour or grant money to 
the authors’ institutions. 
Now two investigators, one 
Dutch and one Czech, have taken 
on the system and fought back. 
They published a paper called 
‘Reaction of Folia Phoniatrica et 
Logopaedica on the current trend 
of impact factor measures’ 
(H. K. Schutte and J. G. Švec 
Folia Phoniatr. Logo. 59, 281–285; 
2007). This cited all the papers 
published in the journal in the 
previous two years. As ‘impact 
factor’ is defined as the number 
of citations to articles in a journal 
in the past two years, divided 
by the total number of papers 
published in that journal over 
the same period, their strategy 
dramatically increased Folia’s 
impact factor this year to 1.439. 
In the ‘rehabilitation’ category, 
shared with 26 other journals, 
Folia jumped from position 22 
to position 13. Publication there 
will now no longer disappoint 
the Dutch author’s colleagues 
for lowering their institution’s 
score, and should encourage 
the Czech government to spend 
more money on the Czech 
author’s university.
Could professional 
scientometrists one day be 
in demand, to guide young 
scientists up the citation ladder 
of scientific survival and allow 
them to do some good, modest 
science in their spare time, just 
for fun? 
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Changing the rules 
won’t stop the rise of 
a new superpower 
SIR — In their Essay ‘The end 
of the science superpowers’ 
(Nature 454, 412–413; 2008), 
J. R. Hollingsworth and 
colleagues argue that the pattern 
of rise and decline of science 
superpowers such as France, 
Germany and Britain is now 
catching up with the United 
States. Surprisingly, they see 
a shift not towards Chinese 
scientific hegemony but towards 
multipolarity. 
They argue that the decline 
of the United States indicates 
the end of a model of scientific 
production, that ‘big’ science 
is finished and that small 
interdisciplinary institutes, where 
new ideas can flourish, are taking 
over. In this context of altered 
dynamics, they conclude that US 
science can prosper alongside 
contributions from elsewhere. 
This argument ignores 
a persistent pattern in the 
history of science. Calls for 
interdisciplinarity and creativity 
always arise when leaders are 
confronted with new competition 
from outside. Such calls are often 
a sign that the callers are losing 
this competition. 
One of the strengths of 
science is that its rules of 
engagement are clear, making it 
possible for anyone to participate 
if they take the effort to learn the 
rules. This means that there is 
always room for newcomers 
taking scientific development to 
its next logical step, overtaking 
formerly dominant elites. As the 
authors point out, this happened 
to France in the mid-nineteenth 
century, to Germany in the 
1920s, and to Britain after the 
Second World War. 
A typical reaction of elites 
under threat is to raise entry 
barriers to their circle by 
placing emphasis on knowledge 
unavailable to newcomers. 
For example, they may trade 
the universal language of their 
science for methods relying 
on culturally specific ‘general 
knowledge’ and interdisciplinary 
meta-perspectives that come 
only with a broad education. 
Laborious scientific methods 
no longer suffice; creativity and 
reflection count. For outsiders, 
the road to success by acquiring 
leadership in specialized fields 
is blocked. 
History teaches us that 
discourses of interdisciplinarity 
and creativity offer temporary 
refuge for embattled elites, but 
eventually do not stop the 
process of shifting scientific 
hegemony. They result in 
isolated, inward-looking 
scientific communities. Much of 
the post-hegemonic academic 
discourse in France and Germany 
illustrates this. If the United 
States is to avoid this fate, it 
should increase scientific funding 
rather than trying to shield itself 
from competition by changing 
the rules. 
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“Oppenheimer told me of a problem 
that was very much on his mind.” 
François de Rose on the birth of CERN, page 174
Doping: similar 
problems arise in 
medical clinics 
SIR — Donald Berry warns 
about the dangers of poor 
statistical understanding and 
misinterpretation of drug-
testing results in Olympic 
athletes. Unfortunately, this 
same problem arises on a 
daily basis around the world in 
medical clinics, often with even 
greater consequences. 
Berry illuminates the 
failure to use proper Bayesian 
reasoning in interpreting 
doping tests and also the 
problem of not having sufficient 
control-population norms 
for the tests to determine 
correctly whether an athlete 
is taking a banned substance 
or not. Clinicians typically 
have less understanding of 
Bayesian statistics than drug-
testing officials and even fewer 
resources to interpret or norm 
such tests. 
Take urine testing of patients 
on opiate therapy to make 
sure that they test positive for 
opiates (to show the patient 
is taking the medicine rather 
than, say, selling it) and that 
they are not using illegal drugs. 
Either a negative test for 
opiates or a positive test for an 
illegal substance can typically 
be sufficient to preclude a 
patient from receiving another 
prescription for opiates or to put 
the clinician in the position of 
having to explain the test result 
before prescribing the medicine. 
Such tests need to be 
reported with the appropriate 
Bayesian interpretation. Also, 
as Berry advocates for Olympic 
athletes, patients should have 
the right (and access) to a 
statistical ‘consultation’ if they 
feel the test is in error.
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